News and Analysis

Cellares locks in $82m Series B

Cellares Corporation, a life sciences technology company, has secured $82 million in Series B funding.

-

Cellares Corporation, a life sciences technology company, has secured $82 million in Series B funding. Decheng Capital and Eclipse Ventures led the round.

Source: Press Release